Characterization of hyperglycemia, hypercholesterolemia, and hyperlipidemia in patients with advanced renal cell carcinoma treated with temsirolimus or interferon-α

被引：0
|
作者：
de Souza, P. L.
Radulovic, S.
Beck, J.
Pendergrass, K.
Siddique, N.
Dutcher, J. P.
Berkenblit, A.
Thiele, A.
Krygowski, M.
Hudes, G. R.
机构：
[1] St George Hosp, Ctr Canc, Kogarah, NSW, Australia
[2] Univ Klini Mainz, Mainz, Germany
[3] Kansas City Canc Ctr, Kansas City, MO USA
[4] Sharp Hlth Care, San Diego, CA USA
[5] Our Lady Mercy Med Ctr, Bronx, NY USA
[6] Wyeth Pharmaceut, Cambridge, MA USA
[7] Fox Chase Canc Ctr, Philadelphia, PA 19111 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2008年 / 26卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5116
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Quality of life in patients with advanced renal cell carcinoma treated with temsirolimus or interferon-α
    Yang, S.
    de Souza, P.
    Alemao, E.
    Purvis, J.
    BRITISH JOURNAL OF CANCER, 2010, 102 (10) : 1456 - 1460
  • [2] Quality of life in patients with advanced renal cell carcinoma treated with temsirolimus or interferon-α
    S Yang
    P de Souza
    E Alemao
    J Purvis
    British Journal of Cancer, 2010, 102 : 1456 - 1460
  • [3] Results of a phase 3, randomized study of patients with advanced renal cell carcinoma (RCC) and poor prognostic features treated with temsirolimus, interferon-α or the combination of temsirolimus plus interferon-α
    De Souza, P.
    Maart, K.
    Laurell, A.
    Hawkins, R. E.
    Berkenblit, A.
    Galand, L.
    Thiele, A.
    Strahs, A.
    Feingold, J.
    Hudes, G.
    EJC SUPPLEMENTS, 2007, 5 (04): : 282 - 283
  • [4] Is advanced renal cell carcinoma best treated with temsirolimus, interferon α, or both?
    Huang, William C.
    NATURE CLINICAL PRACTICE ONCOLOGY, 2008, 5 (01): : 16 - 17
  • [5] Is advanced renal cell carcinoma best treated with temsirolimus, interferon α, or both?
    William C Huang
    Nature Clinical Practice Oncology, 2008, 5 : 16 - 17
  • [6] Analysis of PTEN and HIF-1α and Correlation With Efficacy in Patients With Advanced Renal Cell Carcinoma Treated With Temsirolimus Versus Interferon-α
    Figlin, Robert A.
    de Souza, Paul
    McDermott, David
    Dutcher, Janice P.
    Berkenblit, Anna
    Thiele, Alexandra
    Krygowski, Mizue
    Strahs, Andrew
    Feingold, Jay
    Boni, Joseph
    Hudes, Gary
    CANCER, 2009, 115 (16) : 3651 - 3660
  • [7] Effect of temsirolimus versus interferon-α on outcome of patients with advanced renal cell carcinoma of different tumor histologies
    Dutcher, Janice P.
    de Souza, Paul
    McDermott, David
    Figlin, Robert A.
    Berkenblit, Anna
    Thiele, Alexandra
    Krygowski, Mizue
    Strahs, Andrew
    Feingold, Jay
    Hudes, Gary
    MEDICAL ONCOLOGY, 2009, 26 (02) : 202 - 209
  • [8] Effect of temsirolimus versus interferon-α on outcome of patients with advanced renal cell carcinoma of different tumor histologies
    Janice P. Dutcher
    Paul de Souza
    David McDermott
    Robert A. Figlin
    Anna Berkenblit
    Alexandra Thiele
    Mizue Krygowski
    Andrew Strahs
    Jay Feingold
    Gary Hudes
    Medical Oncology, 2009, 26 : 202 - 209
  • [9] Temsirolimus, interferon alfa, or both for advanced renal-cell carcinoma
    Hudes, Gary
    Carducci, Michael
    Tomczak, Piotr
    Dutcher, Janice
    Figlin, Robert
    Kapoor, Anil
    Staroslawska, Elzbieta
    Sosman, Jeffrey
    McDermott, David
    Bodrogi, Istvan
    Kovacevic, Zoran
    Lesovoy, Vladimir
    Schmidt-Wolf, Ingo G. H.
    Barbarash, Olga
    Gokmen, Erhan
    O'Toole, Timothy
    Lustgarten, Stephanie
    Moore, Laurence
    Motzer, Robert J.
    NEW ENGLAND JOURNAL OF MEDICINE, 2007, 356 (22): : 2271 - 2281
  • [10] Temsirolimus in patients with advanced renal cell carcinoma: an overview
    Shailender Bhatia
    John A. Thompson
    Advances in Therapy, 2009, 26
12345